RT Journal Article
SR Electronic
T1 Narratives of the convalescent plasma donor in a Peruvian social security hospital.: motivations, fears, expectations and experiences
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.02.16.22270690
DO 10.1101/2022.02.16.22270690
A1 Matassini Eyzaguirre, Silvana M.
A1 Yapa, Christian Villanueva
A1 Chunga, Ausberto Chunga
A1 Soto, Arturo Sagastegui
A1 Neyra Vera, Ibeth Melania
A1 Ordoñez, Suly Soto
A1 Román, Martina Guillermo
A1 Miranda, Martin Oyanguren
A1 Soto-Becerra, Percy
A1 Hurtado Roca, Leda Yamileé
A1 Maguiña, Jorge L.
A1 Vladimir, Araujo-Castillo Roger
YR 2022
UL http://medrxiv.org/content/early/2022/02/19/2022.02.16.22270690.abstract
AB Objectives To know and explore from convalescent plasma donator’s voices the experience in the blood donation process at a Peruvian social security hospital.Methods Qualitative study with a phenomenological design. The investigation was carried out in 01 hospitals of the social security of Peru. Semi-structured interviews were carried out.Results Eleven donors of convalescent plasma were interviewed. The main motivations for donating were being able to contribute to national research and supporting patients affected by COVID-19. Fears focus on the possible risk of contagion within the hospital. Donors emphasised the attention and support of health personnel alongside the donation procedure. The main expectations and suggestions point towards greater dissemination of donation campaigns with special emphasis on safety. Likewise, an improvement in the time of the donation procedure (from enrolment to the extraction of convalescent plasma), and the implementation of friendly spaces to encourage future blood donation campaigns were highlighted.Conclusions The experience of the convalescent plasma donors was positive. However, improvements must be made in terms of processes and infrastructure to ensure future successful blood donation campaigns.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Instituto de Evaluacion de Tecnologias en Salud e Investigacion - IETSI, EsSalud, Peru. Likewise, this is an ancillary study to a clinical trial partially funded by the National Council of Science, Technology and Technological Innovation, CONCYTEC, through the National Fund for Scientific, Technological Development and Technological Innovation, FONDECYT, subvention N 068-2020-FONDECYT by Legislative Decree 1473.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the EsSalud Institutional Review Board of COVID studies on December 19, 2020.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.